Australian Pharma Stock News

IperionX Limited has reported half-year results to December 31, 2025, with net loss widening to US$34.77 million and basic and diluted loss per share from continuing operations at US$0.10, compared with US$16.24 million and US$0.06 a year earlier. The earnings release highlights that the company’s sharply higher losses are linked to heavy reinvestment in infrastructure, manufacturing capacity and execution of US government-backed titanium contracts while revenue remains minimal. We will now...

Interest in ASX (ASX:ASX) is picking up as investors look ahead to the biannual ASX SMIDCaps Conference, which is set to spotlight smaller and mid sized companies alongside key reporting updates. See our latest analysis for ASX. At a latest share price of A$49.28, ASX has a 30 day share price return of an 11% decline and a 1 year total shareholder return of a 20.66% decline, pointing to fading momentum even as interest grows around events like the SMIDCaps Conference and broader market...

Lindian Resources (ASX:LIN) share performance context Lindian Resources (ASX:LIN) has drawn attention after a recent move that left the stock showing a 12% return over the past day and more than doubling over the past month. See our latest analysis for Lindian Resources. That sharp move at the latest A$0.91 share price sits on top of a strong run, with a 30 day share price return of about 122% and year to date share price gains above 100%, alongside a very large 1 year total shareholder...

Woodside Energy, in partnership with Petróleos Mexicanos (PEMEX), has begun drilling at the ultra-deepwater Trion Field in the Gulf of Mexico, launching a campaign of 24 subsea wells tied back to the Tláloc floating production unit and the Chalchi floating storage and offloading facility. This move advances one of Mexico’s largest offshore developments, highlighting Woodside’s role as operator with a 60% interest and its growing presence in the Americas deepwater sector. We’ll now explore...

Strickland Metals (ASX:STK) has posted its H1 2026 numbers with revenue of A$2.1 million and a basic EPS loss of A$0.000892 per share, setting a cautious tone around the latest half. The company has seen revenue move from A$1.2 million in H1 2025 to A$7.4 million in H2 2025 and then A$2.1 million in H1 2026, while basic EPS has swung from a loss of A$0.0014 in H1 2025 to a profit of A$0.003091 in H2 2025 before slipping back to a small loss in the latest half, putting the spotlight firmly on...

If you are wondering whether Ora Banda Mining is priced attractively or already reflecting a lot of optimism, its recent share performance and valuation checks provide several points to consider. The stock last closed at A$1.35, with returns of 2.3% over 7 days, 5.9% over 30 days, a 12.3% decline year to date, and a 22.7% gain over the past year. The 3 year return is very large and the 5 year return is close to 5x. Recent news coverage has focused on Ora Banda Mining's position within the...

DroneShield has recently set up counter-drone manufacturing within the European Union through a local partner, with production underway and first deliveries scheduled for mid-2026. This move anchors DroneShield inside the EU defence supply chain, potentially shortening delivery timelines for European customers and reinforcing local sovereignty requirements. We’ll now explore how this new EU-based production capacity could influence DroneShield’s investment narrative and long-term growth...

Cyprium Metals (ASX:CYM) opened its H1 2026 update with trailing twelve month revenue of A$9.8 million and a basic EPS loss of A$0.051, alongside a net income loss of A$17.0 million. This set a clear focus on how efficiently new revenue is being converted into earnings. The company has seen total revenue move from A$0 in H2 2025 to A$9.8 million on a trailing basis, while basic EPS shifted from a loss of A$0.150 in H2 2025 to a trailing loss of A$0.051. This gives investors fresh context on...

Why Computershare is on investors’ radar today With no single headline event driving Computershare (ASX:CPU) today, the focus is on how its current share price of A$28.99 lines up against its recent returns and underlying business profile. See our latest analysis for Computershare. Recent trading has been weak, with a 1-day share price return of a 1.06% decline and a 30-day share price return of a 10.25% decline at A$28.99, while the 5-year total shareholder return of 129.24% highlights how...

In early March 2026, Telix Pharmaceuticals reported that Part 1 of its ProstACT Global Phase 3 trial for TLX591-Tx in metastatic castration-resistant prostate cancer met its primary safety and dosimetry objectives, with an acceptable tolerability profile and no new safety signals across combinations with standard-of-care therapies. A distinctive aspect for investors is that TLX591-Tx’s antibody-based design showed minimal kidney, salivary and lacrimal gland exposure versus existing...

Downer EDI Limited has continued its on‑market share buy-back in recent months, repurchasing more than 9.29 million shares as part of its previously announced capital management program, according to past ASX filings up to March 2026. This sustained buy-back effort is materially shrinking the share count, which can influence earnings per share and the ownership mix for remaining investors. We’ll now examine how Downer EDI’s ongoing on‑market buy-back program may influence its investment...

In recent months, Vault Minerals has continued its on-market share buy-back program, with cumulative repurchases surpassing 5.8 million ordinary shares as of 12 March 2026. This ongoing reduction in share count offers investors fresh insight into the company’s capital management priorities and evolving ownership structure. We’ll now examine how Vault Minerals’ ongoing on-market share buy-back activity shapes its investment narrative and potential capital allocation appeal. Outshine the...

Sonic Healthcare, one of the world’s largest pathology providers, has recently attracted fresh attention as its current valuation sits below its historical average price-to-sales ratio despite a period of revenue growth and weaker profit outcomes over the past three years. This mix of apparent value and profitability pressure is prompting investors to reassess whether the company’s scale and service mix can offset its recent challenges. We’ll now examine how Sonic Healthcare’s apparent...

Aristocrat Leisure (ASX:ALL) has drawn investor attention after director Natasha Chand increased her direct shareholding and the company reported further progress in its ongoing on market share buy back program. See our latest analysis for Aristocrat Leisure. Those insider moves come after a tough stretch for the stock, with a 30 day share price return of 13.21% and a year to date share price return of 20.22%. The 1 year total shareholder return of 30.42% contrasts with 3 and 5 year total...

Helia Group recently reported strong FY25 results, including higher net profit and a solid capital position, and its shares have now traded ex-dividend ahead of a large final fully franked dividend and a partially franked special dividend that together reflect a 14% cash yield before franking. By fully paying out statutory NPAT while also shrinking its capital base, Helia is leaning heavily into capital return, raising fresh questions about how it balances near-term income for shareholders...

If you are wondering whether Commonwealth Bank of Australia (CBA) is priced fairly or carrying a premium at around A$171.60 per share, you are not alone. Many investors are asking the same question right now. CBA's share price has been relatively steady over the past week with a 0.6% decline, while the stock shows returns of 8.1% over 30 days, 6.5% year to date, 22.6% over 1 year, 99.5% over 3 years and 140.0% over 5 years. Recent news coverage around CBA has largely focused on its role as a...

Lynas Rare Earths (ASX:LYC) is back on investor radars after extending its supply agreement with Japan Australia Rare Earths to 2038, adding price floors, upside sharing, and renewed Malaysian operating certainty. See our latest analysis for Lynas Rare Earths. The extended JARE deal and Malaysian licence renewal have arrived alongside strong momentum, with a 30 day share price return of 39.83% and a year to date share price return of 73.24%. The 1 year total shareholder return of 191.60% and...

In recent days, Whitehaven Coal has secured stable credit ratings from S&P, Fitch and Moody’s to refinance a major acquisition loan and has continued its on‑market share buy-back, repurchasing more than one million shares as part of its capital management program. Together, the stronger credit profile and active buy-back point to a company placing greater emphasis on funding flexibility, balance sheet strength and shareholder returns. We’ll now examine how Whitehaven’s new credit ratings,...

CSL has recently broken ground on a US$1.50 billion expansion of its Kankakee, Illinois plasma-therapy manufacturing facility, adding at least 300 new pharmaceutical jobs and incorporating its patented Horizon 2 process to increase immunoglobulin and albumin production capacity by 2031. This large-scale build-out not only deepens CSL’s U.S. manufacturing footprint but also advances its goal of end-to-end plasma processing within the United States, which may be important for supply resilience...

Fortescue has commenced construction of its 440MW Solomon Airport solar project in the Pilbara, set to become Western Australia’s largest solar farm and a core element of its Real Zero decarbonisation plans, with completion targeted for 2028 and about 671,000 panels installed. This large-scale solar build signals Fortescue’s push to reduce reliance on traditional fuels at its mining operations while expanding its renewable energy footprint alongside iron ore. We’ll now examine how this major...

Origin Energy in focus after oil price spike The recent surge in oil prices above US$100 per barrel has sharpened attention on Origin Energy (ASX:ORG), given its 27.5% interest in the Australia Pacific LNG project and exposure to higher LNG pricing. See our latest analysis for Origin Energy. Despite the latest share price of A$11.59 and a 1-day share price return decline of 0.34%, Origin’s 30-day share price return of 5.46% and 1-year total shareholder return of 19.41% suggest momentum has...

China Mineral Resources Group has widened its ban on BHP's iron ore, now blocking Newman fines shipments to Chinese steel mills. The move intensifies contract talks and touches BHP's core iron ore revenue base at a sensitive moment for seaborne pricing. Separately, BHP is in advanced talks to sell its West Musgrave copper nickel project, with South32 reported as a leading bidder. These developments point to a possible reshaping of ASX:BHP's exposure to China and to future-facing metals such...

Australian Strategic Materials (ASX:ASM) has just posted its H1 2026 scorecard, with trailing 12 month revenue of A$10.1 million and a net loss of A$21.6 million, translating to a basic EPS loss of A$0.11. Over recent half year periods the company has seen revenue move from A$1.96 million in H2 2024 to A$2.20 million in H1 2025 and A$2.89 million in H2 2025, while basic EPS losses shifted from A$0.10 to A$0.08 and then A$0.06, setting up a results story where investors are weighing growing...

Elsight (ASX:ELS) is back on investor radars after securing a US$21.2 million contract with a European defence drone manufacturer. This development is supported by new senior hires and early deliveries of its Aura communications device. See our latest analysis for Elsight. The contract news and senior hires come after a strong run in Elsight’s shares, with a 49.5% 30 day share price return and a 1 year total shareholder return that is well into double digit multiples. This indicates strong...